Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
CCT251545 alters WNT pathway-regulated gene expression and other on-target effects of modulating CDK8 and CDK19
InChiKey: QQLKULDARVNMAL-UHFFFAOYSA-N
Chemical Name: N-(2-chloro-5-methoxyphenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine
14(9):1061-9
Repaglinide Catalog No.:M10285-2 CCT251545 alters WNT pathway-regulated geneRepaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. The mechanism of action of repaglinide involves promoting insulin release from islet cells of the pancreas. Product information CAS Number: 135062 02 1 Molecular Weight: 452. 59 Formula: C27H36N2O4 Chemical Name: 2